English
FranįaisObbligazione Teva Pharmaceutical Finance Netherlands III B.V 8.125% ( US88167AAR23 ) in USD
| Emittente | Teva Pharmaceutical Finance Netherlands III B.V |
| Prezzo di mercato |  111.39 USD ▼ |
| Paese |  Israele
|
| Codice isin |
 US88167AAR23 ( in USD )
|
| Tasso d'interesse | 8.125% per anno ( pagato 2 volte l'anno) |
| Scadenza | 14/09/2031 |
|
La brochure del prospetto in formato PDF non č al momento disponibile Lo forniremo il prima possibile |
|
| Importo minimo | 200 000 USD |
| Importo totale | 500 000 000 USD |
| Cusip | 88167AAR2 |
| Standard & Poor's ( S&P ) rating | BB ( Non-investment grade speculative ) |
| Moody's rating | Ba2 ( Non-investment grade speculative ) |
| Coupon successivo | 15/09/2025 ( In 149 giorni ) |
| Descrizione dettagliata |
Teva Pharmaceutical Finance Netherlands III B.V. č una societā sussidiaria di Teva Pharmaceutical Industries Ltd., con sede nei Paesi Bassi, che opera nel settore finanziario a supporto delle attivitā del gruppo farmaceutico. The Obbligazione issued by Teva Pharmaceutical Finance Netherlands III B.V ( Israel ) , in USD, with the ISIN code US88167AAR23, pays a coupon of 8.125% per year. The coupons are paid 2 times per year and the Obbligazione maturity is 14/09/2031 The Obbligazione issued by Teva Pharmaceutical Finance Netherlands III B.V ( Israel ) , in USD, with the ISIN code US88167AAR23, was rated Ba2 ( Non-investment grade speculative ) by Moody's credit rating agency. The Obbligazione issued by Teva Pharmaceutical Finance Netherlands III B.V ( Israel ) , in USD, with the ISIN code US88167AAR23, was rated BB ( Non-investment grade speculative ) by Standard & Poor's ( S&P ) credit rating agency. |